ImmunityBio GAAP EPS of -$0.18 misses by $0.10, revenue of $48.84M misses by $10.39M
Open the sourceReported by Seeking Alpha, seekingalpha.com, 9 November 2026
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.